SphK

鞘氨醇激酶 (SphK1 和 SphK2) 是一种脂质酶,可催化鞘氨醇磷酸化形成鞘氨醇 1-磷酸 (S1P)。在哺乳动物中发现了两种 SphK 同工酶,即 SphK1 和 SphK2。SphK1 主要存在于红细胞、内皮细胞和肥大细胞的细胞质和质膜中。SphK2 较大,位于内质网、细胞核和线粒体中。

S1P 与五种不同的质膜鞘氨醇 1-磷酸受体 (S1P1-5) 结合,并可调节细胞内靶蛋白。S1P 具有广泛的生物学功能,包括促进细胞增殖和存活、免疫细胞运输、刺激血管生成和调节血管完整性。S1P 的积累与癌症和各种其他疾病的发展/进展有关,包括但不限于哮喘、炎症性肠病、类风湿性关节炎和糖尿病性肾病。因此,S1P 的生物合成途径是药物发现的合理目标。SphK1 和 SphK2 同工酶也是公认的治疗靶点。

Sphingosine kinase (SphK1 and SphK2) is a lipid enzyme that catalyses the phosphorylation of sphingosine to form sphingosine 1-phosphate (S1P). Two isoforms of SphK are found in mammalian organisms, SphK1 and SphK2. SphK1 is found primarily in the cytoplasm and the plasma membrane of erythrocyte, endothelial and mast cells. SphK2 is larger and localized to the endoplasmic reticulum, nucleus, and mitochondria.

S1P binds to five different plasma membrane sphingosine 1-phosphate receptors (S1P1-5) and can regulate intracellular target proteins. S1P has a wide range of biological functions including promotion of cellular proliferation and survival, immune cell trafficking, stimulation of angiogenesis, and regulation of vascular integrity. Accumulation of S1P has been linked to the development/progression of cancer and various other diseases including, but not limited to, asthma, inflammatory bowel disease, rheumatoid arthritis, and diabetic nephropathy. Thus, the biosynthetic route to S1P is a logical target for drug discovery. SphK1 and SphK2 isozymes are also recognized therapeutic targets.

SphK亚型特异性产品:SphK Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PPI-4955

PPI-4955 是一种鞘氨醇-1-磷酸受体亚型 1 (S1P₁) 激动剂(EC50 为 1.62 nM),其活性磷酸化形式 PPI-4955-P 表现出卓越的受体选择性和亲和力,对 hS1P₁、hS1P3、hS1P4 和 hS1P5 的 IC50 分别为 0.23、2000、6.5 和 184 nM,同时 PPI-4955 具有显著提高的体内磷酸化效率,可减少淋巴细胞并改善心血管风险,可用于免疫调节研究。

911412-31-2
Agonist
PPI-4955

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础